Taro Pharmaceutical Industries Ltd. (TARO)
Jun 24, 2024 - TAR was delisted (reason: acquired by Sun Pharma)
42.97
0.00 (0.00%)
Last trade price

TARO Revenue

In the fiscal year ending March 31, 2024, Taro Pharmaceutical Industries had annual revenue of $629.18M with 9.81% growth. Revenue in the quarter ending March 31, 2024 was $164.94M with 12.52% year-over-year growth.

Revenue (ttm)
$629.18M
Revenue Growth
+9.81%
P/S Ratio
2.57
Revenue / Employee
$404,879
Employees
1,554
Market Cap
1.62B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2024629.18M56.23M9.81%
Mar 31, 2023572.95M11.61M2.07%
Mar 31, 2022561.35M12.38M2.25%
Mar 31, 2021548.97M-95.80M-14.86%
Mar 31, 2020644.77M-25.12M-3.75%
Mar 31, 2019669.89M7.98M1.21%
Mar 31, 2018661.91M-217.47M-24.73%
Mar 31, 2017879.39M-71.36M-7.51%
Mar 31, 2016950.75M87.81M10.18%
Mar 31, 2015862.94M103.66M13.65%
Mar 31, 2014759.29M88.33M13.16%
Mar 31, 2013670.95M127.87M23.55%
Mar 31, 2012543.08M37.41M7.40%
Dec 31, 2011505.67M113.13M28.82%
Dec 31, 2010392.54M36.60M10.28%
Dec 31, 2009355.94M26.90M8.18%
Dec 31, 2008329.04M9.48M2.97%
Dec 31, 2007319.55M67.29M26.67%
Dec 31, 2006252.27M-36.35M-12.60%
Dec 31, 2005288.62M17.64M6.51%
Dec 31, 2004270.99M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.